BIOMAT Database Logo BIOMAT Database Logo

[APPLICATION OF IMMUNOCHEMICAL TECHNICS TO THE STUDY OF FIBRINOGEN AND ITS PRODUCTS OF DEGRADATION BY PLASMIN]. 1965

M SELIGMANN, and V MARDER

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M SELIGMANN, and V MARDER
Characterization of the terminal degradation products of canine fibrinogen by plasmin.
March 1975, Biochimica et biophysica acta,
M SELIGMANN, and V MARDER
The effect of fibrinogen degradation products on plasmin activity.
June 1973, Thrombosis et diathesis haemorrhagica,
M SELIGMANN, and V MARDER
Anticoagulant peptides obtained from human fibrinogen degradation products by plasmin.
January 1979, Thrombosis research,
M SELIGMANN, and V MARDER
Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen.
January 1971, Scandinavian journal of haematology. Supplementum,
M SELIGMANN, and V MARDER
Degradation pathway of fibrinogen by plasmin.
December 1977, Thrombosis and haemostasis,
M SELIGMANN, and V MARDER
Degradation of human fibrinogen by plasmin: a kinetic study.
March 1977, Thrombosis research,
M SELIGMANN, and V MARDER
[The products of degradation of human fibrinogen by plasmin. I. Separation and physicochemical properties].
March 1961, Annales de l'Institut Pasteur,
M SELIGMANN, and V MARDER
Unknown properties of the products of plasmin-degradation of fibrinogen and fibrin.
January 1966, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,
M SELIGMANN, and V MARDER
[The degradation products of human fibrinogen by plasmin. II. Immunological study: existence of native anti-fibrinogen antibodies possessing different specificities].
April 1961, Annales de l'Institut Pasteur,
M SELIGMANN, and V MARDER
A structural aspect of human fibrinogen suggested by its plasmin degradation.
June 1971, FEBS letters,
Copied contents to your clipboard!